- Vector-based Cas
- DNA-free Cas
CRISPR Market size is valued at USD 1,087.2 million in 2021 and is expected to reach USD 5,068.9 million by 2028, at a CAGR of 24.6% during the forecast period 2022-2028. CRISPR is an acronym for Clustered Regularly Interspaced Short Palindromic Repeat. CRISPR is also called as CRISPR/Cas9. The scientific world is attracted by this revolutionary technology. CRISPR technology is a simple yet powerful tool that is used for editing genomes. This technology is used to alter the DNA sequence and modify gene function. Its major application includes correcting genetic defects, treating, and preventing the spread of diseases and is also used improving crops. The technological advancements are the key factors attributed for the growth of the CRISPR market. Increase in the prevalence of genetic and growing drug discovery activities are expected to boost the market revenue growth. The growing demand for synthetic genes and increase in the R&D expenditure on biotechnology and raising government expenditure on genetic research is enriching the growth of the CRISPR market. However, complications such as gene editing of germ line cells are hindering the growth of the market. Since the changes made in germ line cells are transferred to the next generations. The gene editing of germ line cells also has ethical issues and is illegal in most of the countries such as the UK. Limited awareness is another factor hindering the growth of the CRISPR market. this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global CRISPR Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global CRISPR Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).Â
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
During the projected period, technological developments in CRISPR and the launch of anti-CRISPR proteins are expected to drive the market. The market is predicted to develop due to the growing acceptance of CRISPR technology in pharmaceuticals, epigenetics, plant genome editing, human germline editing, and other disciplines of biotechnology. CRISPR-Cas systems also have uses in culture immunisation, self-targeted cell death, bacterial strain typing, and altering metabolic pathways to increase biochemical synthesis, all of which contribute to the global market's expansion.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.